Don't miss our LEUKEMIA 360 partnership event, registration is limited! Access the website

  • Clinical development
  • AML
  • Targeted therapy
  • Immunotherapy
  • Clinical research (TRL 6-8)

Retrospective analyses of patient data from the Hauts de France AML Observatory.

The Hauts-de-France Observatory gathers initial and follow-up clinical and biological data on adult patients with AML diagnosed in clinical hematology centers in the Hauts-de-France region. In 2022, this observatory included data on around 2,500 patients.


Description

Scope of research activities

Clinical research into AML pathology, with the aim of improving patient care and quality of life:

  • Non-interventional clinical research

Role  

  • Provision of clinical and biological data
  • Participation in the analysis of extracted data

Infrastructure 

Analysis platforms:

  • Database / eCRF

Models:

  • Primary cells from clinical study patients

Technical personnel:

  • 2 clinical research associates

Specifications

The platform

Platform for retrospective analysis of AML observatory data:

Studies 

Data study

  • Frequency of a clinical or biological parameter
  • Study of a population defined according to clinical, biological or demographic criteria

Examples of partnerships

Establishment of a validation cohort for AML in elderly adult - The study aimed to establish a cohort of patients with the same characteristics as those included in the ALFA-1200 protocol in order to validate a prognostic score based on genetic alterations.

Partner: ALFA Group


Terms

  • Clinical research project with industrial sponsoring
  • Partnership agreement with study sponsor
Contact us